EUVIMEDEUVIMED entdecken
Crossref

Pharmacological Treatment of Acute Spinal Cord Injuries In The Light Of Recent Developments

Mürteza Çakır

Recent Trends in Pharmacology · 2024

DOI: 10.62425/rtpharma.1458517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Recent Trends in Pharmacology, 2024. Verfasst von Mürteza Çakır. Die Arbeit nennt 65 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal injuries represent a significant public health issue with both individual and societal implications due to its potential to result in long-term or permanent disability and death. Today, notwithstanding the comprehensive elucidation of the mechanism of injury in its all aspects and breakthroughs in early diagnosis techniques and treatment, spinal injuries still retain their devastating nature. Although many agents hypothesized to possess neuroprotective and neuroregenerative properties have been demonstrated to be effective in the experiments, research involving human subjects is still in progress, offering promising developments. Methylprednisolone at a high dose is the most extensively investigated therapeutic for acute spinal injuries. Despite significant controversy, it remains a viable treatment option. It is anticipated that combining stem cell transplantation with multiple pharmacological agents will yield more favorable outcomes.

Zitieren

APA

Çakır, M. (2024). Pharmacological Treatment of Acute Spinal Cord Injuries In The Light Of Recent Developments. Recent Trends in Pharmacology. https://doi.org/10.62425/rtpharma.1458517

Vancouver

Çakır M. Pharmacological Treatment of Acute Spinal Cord Injuries In The Light Of Recent Developments. Recent Trends in Pharmacology. 2024. doi:10.62425/rtpharma.1458517

BibTeX
@article{akr2024,
  author = {Çakır, Mürteza},
  title = {Pharmacological Treatment of Acute Spinal Cord Injuries In The Light Of Recent Developments},
  journal = {Recent Trends in Pharmacology},
  year = {2024},
  doi = {10.62425/rtpharma.1458517}
}
Kostenlos starten →